Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind multicenter study of different induction doses of GR1501 injection in plaque psoriasis
CTR20233886Phase 2Completed
- Sponsor
- Zhixiang Jintai
- Start
- Dec 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of xeligekimab in plaque psoriasis, sponsored by Zhixiang Jintai. Started Dec 2023; status: completed.
02
Drugs
xeligekimab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20233886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233886.